Search
for
Sort by
Research 211–240 of 1000+
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Interventions for nail psoriasis
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Janus Kinase inhibitors in dermatology: a review
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Pharmacotherapy of alopecia areata
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Sanna Makki (Cassia angustifolia Vahl.): An Ancient Remedy in Modern Pharmacology: An Overview
- Evidence for the off-label use of tofacitinib in alopecia areata
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Minoxidil in the treatment of alopecia areata
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Reporting on Adverse Clinical Events
- Current and future pharmacotherapy for alopecia areata
- SCALP HAIR CHARACTERISTICS IN THE NEWBORN INFANT
- Teriflunomide in multiple sclerosis: an update
- Ottawa, Ontario, Canada, February 13–16, 2013
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide